The pharmaceutical industry is continually seeking novel approaches to create and identify effective treatments that cater to medical requirements. The procedure of discovering drugs is a daunting process that demands significant resources. Recently, this method has undergone significant advancements due to the integration of machine learning (ML) and artificial intelligence (AI) technologies.
These advanced tools offer exciting opportunities to expedite drug development with their ability to discover novel targets, optimize core compounds, and predict potential efficacy while ensuring safety for patients. This essay aims to examine in detail how these technologies can transform drug discovery by shedding light on its impact on the pharmaceutical industry landscape through various applications.
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.
